This heterogeneity likely arises from multiple sources, including differences in irisin detection methods (e.g., varying ELISA kits), biospecimen types (serum vs. plasma), population characteristics (e.g., geographic region, ethnicity, diabetes duration), and diagnostic criteria for diabetic nephropathy. This evidence concerns the gene FNDC5 and diabetic kidney disease.